AbbVie is a research-based biopharmaceutical company known for its blockbuster drug Humira. Let's check out the charts and indicators.
In this daily bar chart of (ABBV) , below, we can see that prices rallied back above the 50-day moving average line after touching/testing the rising 200-day line earlier this month. The On-Balance-Volume (OBV) line weakened in April and May and bottomed in June suggesting a shift back to aggressive buying from aggressive selling. The Moving Average Convergence Divergence (MACD) oscillator has crossed to the upside for a cover shorts buy signal.